The emergence of precision urologic oncology: a collaborative review on biomarker-driven therapeuticsMore about Open Access at the Crick
Authors listChristopher E Barbieri Arul M Chinnaiyan Seth P Lerner Charles Swanton Mark A Rubin
Biomarker-driven cancer therapy, also referred to as precision oncology, has received increasing attention for its promise of improving patient outcomes by defining subsets of patients more likely to respond to various therapies.
Journal European Urology
Issue number 2